Qvt Financial LP Biomarin Pharmaceutical Inc Transaction History

Qvt Financial LP

$1.04 Billion
Q3 2024

A detailed history of Qvt Financial LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Qvt Financial LP holds 4,429 shares of BMRN stock, worth $280,621. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,429

Previous 4,429 -0.0%

Holding current value

$280,621

Previous $364,000 14.56%

% of portfolio

0.03%

Previous 0.04%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $244,180 - $285,998	-2,900 Reduced 39.57%	4,429 $393,000
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $524,012 - $682,712	-6,894 Reduced 48.47%	7,329 $690,000
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $132,039 - $157,471	-1,700 Reduced 10.68%	14,223 $1.15 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $2,584 - $3,044	32 Added 0.2%	15,923 $1.42 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.28 Million - $1.51 Million	15,891	15,891 $1.48 Million

Others Institutions Holding BMRN

# of Institutions

644

Shares Held

178M

Call Options Held

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Qvt Financial LP with notifications on news.

Account